Related references
Note: Only part of the references are listed.Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease Two Case Reports
Zinovia Kefalopoulou et al.
JAMA NEUROLOGY (2014)
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease
Roger A. Barker et al.
LANCET NEUROLOGY (2013)
Improved Cell Therapy Protocols for Parkinson's Disease Based on Differentiation Efficiency and Safety of hESC-, hiPSC-, and Non-Human Primate iPSC-Derived Dopaminergic Neurons
Maria Sundberg et al.
STEM CELLS (2013)
Therapies in Parkinson's disease
Joseph Jankovic et al.
CURRENT OPINION IN NEUROLOGY (2012)
Capture of Neuroepithelial-Like Stem Cells from Pluripotent Stem Cells Provides a Versatile System for In Vitro Production of Human Neurons
Anna Falk et al.
PLOS ONE (2012)
Generation of Regionally Specified Neural Progenitors and Functional Neurons from Human Embryonic Stem Cells under Defined Conditions
Agnete Kirkeby et al.
CELL REPORTS (2012)
Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants
Marios Politis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
T Foltynie et al.
BRAIN (2004)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
JH Kim et al.
NATURE (2002)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
